We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

Geron Announces Initiation of Phase I Clinical Trial of Vaccine Candidate Targeting Telomerase by Merck

The trial will assess the safety, tolerability and immunogenicity of the non-dendritic cell based cancer vaccine in patients with solid tumors.
News

Vical Receives Milestone Payment from Merck Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

Vical announces receipt of a $1.0 million milestone based on Merck's planned initiation of a Phase I clinical trial of pDNA cancer vaccine.
News

Celldex Announces Licensing Agreement for Cancer Antibody Program

Celldex enters an exclusive patent and know-how license agreement with the University of Southampton, UK, to develop human antibodies towards CD27.
News

Canopus BioPharma Announces Positive Results in Human Study of Peptide Cancer Vaccine

Study analyzed at Southern Research Institute shows human antibodies generated by Canopus’s peptides have anti-cancer properties.
News

Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention

The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies – such as HPV testing and HPV vaccines - that are helping to eradicate cervical cancer globally.
News

Immutep Reports that LAG-3 Enhances Activity of a Cellular Cancer Immunotherapy in Preclinical Studies

Research paper describes increase in potency of a GM-CSF-secreting tumor cell immunotherapy by a LAG-3 fusion protein immunopotentiator.
News

Cell Genesys Reports Interim Data from Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer

Sixteen patients have completed dosing of CG0070 administered once weekly or once every four weeks at the two lowest of three doses being evaluated.
News

Advances in Microarray Technology Conference Biggest Ever

Select BioSciences’ AMT event held in Barcelona was well attended, with more than 400 participants, around 40 exhibitors and a full two-day programme.
News

Mouse Studies Show Tumors Suppress Cells Responsible for Regulating the Immune System

New research has shown that the function of a type of cell that helps modulate immune responses is impaired inside tumors in mice.
News

Cell Genesys and Takeda Announce Global Development and Commercialization Alliance

The agreement aims at developing and commercializing Cell Genesys' GVAX immunotherapy for prostate cancer.
Advertisement